AKT1 and cancer: GSK-3 is a common kinase involved in the regulation of many oncogenic pathways, including Wnt/β-catenin and PI3K/PTEN/Akt/mTORC, and its deregulation by inhibitory phosphorylation results in EMT and cancer progression [47].